TTK Healthcare Limited (BOM:507747)
912.95
-3.85 (-0.42%)
At close: Nov 6, 2026
TTK Healthcare Revenue
TTK Healthcare had revenue of 2.52B INR in the quarter ending September 30, 2026, with 23.85% growth. This brings the company's total for the last twelve months to 9.17B, up 11.12% year-over-year. In the fiscal year ending March 31, 2026, TTK Healthcare had annual revenue of 8.57B with 6.96% growth. That makes TTK Healthcare the 22,838th largest company in the world by revenue and 1,382nd in India.
Revenue (ttm)
9.17B
Revenue Growth
+11.12%
P/S Ratio
1.40
Revenue / Employee
6.63M
Employees
1,384
Market Cap
12.90B
Revenue by Segment
Fiscal year ended Mar 31, 2026 See the full TTK Healthcare breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 8.57B | 557.88M | 6.96% |
| Mar 31, 2025 | 8.01B | 487.00M | 6.47% |
| Mar 31, 2024 | 7.53B | 276.84M | 3.82% |
| Mar 31, 2023 | 7.25B | 1.26B | 21.01% |
| Mar 31, 2022 | 5.99B | 1.23B | 25.88% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Venus Remedies | 8.37B |
| Kopran | 7.94B |
| Sudarshan Pharma Industries | 7.80B |
| Anuh Pharma | 7.78B |
| Lincoln Pharmaceuticals | 7.22B |
| Wanbury | 6.76B |
| Amrutanjan Health Care | 5.27B |
| Fermenta Biotech | 5.07B |
TTK Healthcare News
- 3 months ago - Wipro Consumer Care buys TTK’s Good Home, Eva brands for Rs 256 cr - The Times of India